{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:52:58Z","timestamp":1773341578138,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35774-1","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:35:33Z","timestamp":1770975333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary exploration of radiomic mammographic analysis in triple negative breast cancer related to BRCA profile"],"prefix":"10.1038","volume":"16","author":[{"given":"Annarita","family":"Pecchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Nocetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Bozzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Balboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Besutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Toss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cortesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Torricelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"9","key":"35774_CR1","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1245\/s10434-015-4371-0","volume":"22","author":"V Guarneri","year":"2015","unstructured":"Guarneri, V. et al. Preoperative carboplatin\u2013paclitaxel\u2013 bevacizumab in triple-negative breast cancer: final results of the phase II Ca.Pa.Be study. Ann. Surg. Oncol. 22(9), 2881\u20132887 (2015).","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"35774_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100694","volume":"3","author":"L Jiang","year":"2022","unstructured":"Jiang, L. et al. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer. Cell Rep. Med. 3(7), 100694. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100694 (2022).","journal-title":"Cell Rep. Med."},{"key":"35774_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin, L., Duan, J. J., Bian, X. W. & Yu, S. C. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 22, 61. https:\/\/doi.org\/10.1186\/s13058-020-01296-5 (2020).","journal-title":"Breast Cancer Res."},{"key":"35774_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2024.110214","volume":"113","author":"A Pecchi","year":"2024","unstructured":"Pecchi, A. et al. DCE-MRI radiomic analysis in triple-negative ductal invasive breast cancer: comparison between BRCA and non-BRCA mutated patients. Magn. Reson. Imaging 113, 110214. https:\/\/doi.org\/10.1016\/j.mri.2024.110214 (2024).","journal-title":"Magn. Reson. Imaging"},{"issue":"3","key":"35774_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1067\/j.cpradiol.2020.01.011","volume":"50","author":"N Karbasian","year":"2021","unstructured":"Karbasian, N. et al. Imaging features of triple-negative breast cancer and the effect of BRCA mutations. Curr. Probl. Diagn. Radiol. 50(3), 316\u2013322. https:\/\/doi.org\/10.1067\/j.cpradiol.2020.01.011 (2021).","journal-title":"Curr. Probl. Diagn. Radiol."},{"issue":"4","key":"35774_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2214\/AJR.16.16957","volume":"209","author":"SM Ha","year":"2017","unstructured":"Ha, S. M. et al. Association of BRCA mutation types, imaging features, and pathologic findings in patients with breast cancer with BRCA1 and BRCA2 mutations. AJR Am. J. Roentgenol. 209(4), 920\u2013928. https:\/\/doi.org\/10.2214\/AJR.16.16957 (2017).","journal-title":"AJR Am. J. Roentgenol."},{"key":"35774_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1471-2407-8-155","volume":"8","author":"DG Gareth","year":"2008","unstructured":"Gareth, D. G. et al. Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting. BMC Cancer 8, 155. https:\/\/doi.org\/10.1186\/1471-2407-8-155 (2008).","journal-title":"BMC Cancer"},{"issue":"3","key":"35774_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10549-017-4198-4","volume":"163","author":"J Krammer","year":"2017","unstructured":"Krammer, J. et al. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. Treat. 163(3), 565\u2013571. https:\/\/doi.org\/10.1007\/s10549-017-4198-4 (2017).","journal-title":"Breast Cancer Res. Treat."},{"key":"35774_CR9","doi-asserted-by":"publisher","first-page":"175883592097532","DOI":"10.1177\/1758835920975326","volume":"12","author":"L Incorvaia","year":"2020","unstructured":"Incorvaia, L. et al. BRCA1\/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype\u2013phenotype correlation in a cohort of 531 patients. Ther. Adv. Med. Oncol. 12, 1758835920975326. https:\/\/doi.org\/10.1177\/1758835920975326 (2020).","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"1","key":"35774_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.21037\/gs-20-596","volume":"10","author":"C You","year":"2021","unstructured":"You, C. et al. Clinicopathological and MRI features of patients with BRCA1\/2 mutations in familial breast cancer. Gland Surg. 10(1), 262\u2013272. https:\/\/doi.org\/10.21037\/gs-20-596 (2021).","journal-title":"Gland Surg."},{"issue":"5","key":"35774_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/mps5050078","volume":"5","author":"F Gallivanone","year":"2022","unstructured":"Gallivanone, F., Bertoli, G. & Porro, D. Radiogenomics, breast cancer diagnosis and characterization: current status and future directions. Methods Protoc. 5(5), 78. https:\/\/doi.org\/10.3390\/mps5050078 (2022).","journal-title":"Methods Protoc."},{"key":"35774_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.37349\/etat.2022.00113","volume":"3","author":"M C\u00e8","year":"2022","unstructured":"C\u00e8, M. et al. Artificial intelligence in breast cancer imaging: risk stratification, lesion detection and classification, treatment planning and prognosis. Explor. Target Antitumor Ther. 3, 113\u2013127. https:\/\/doi.org\/10.37349\/etat.2022.00113 (2022).","journal-title":"Explor. Target Antitumor Ther."},{"issue":"2","key":"35774_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.17691\/stm2021.13.2.11","volume":"13","author":"AA Litvin","year":"2021","unstructured":"Litvin, A. A. et al. Radiomics and digital image texture analysis in oncology. Sovreme. Tehnologii Med. 13(2), 11. https:\/\/doi.org\/10.17691\/stm2021.13.2.11 (2021).","journal-title":"Sovreme. Tehnologii Med."},{"issue":"8","key":"35774_CR14","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.acra.2021.09.025","volume":"29","author":"S Siviengphanom","year":"2022","unstructured":"Siviengphanom, S. et al. Mammography-based radiomics in breast cancer: a scoping review of current knowledge and future needs. Acad. Radiol. 29(8), 1170\u20131182. https:\/\/doi.org\/10.1016\/j.acra.2021.09.025 (2022).","journal-title":"Acad. Radiol."},{"key":"35774_CR15","doi-asserted-by":"publisher","first-page":"1390342","DOI":"10.3389\/fonc.2024.1390342","volume":"14","author":"W Li","year":"2024","unstructured":"Li, W. et al. Radiomics analysis combining gray-scale ultrasound and mammography for differentiating breast adenosis from invasive ductal carcinoma. Front. Oncol. 14, 1390342. https:\/\/doi.org\/10.3389\/fonc.2024.1390342 (2024).","journal-title":"Front. Oncol."},{"key":"35774_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2023.107857","volume":"243","author":"T Lv","year":"2024","unstructured":"Lv, T. et al. AI-powered interpretable imaging phenotypes noninvasively characterize tumor microenvironment associated with diverse molecular signatures and survival in breast cancer. Comput. Methods Programs Biomed. 243, 107857. https:\/\/doi.org\/10.1016\/j.cmpb.2023.107857 (2024).","journal-title":"Comput. Methods Programs Biomed."},{"key":"35774_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10549-018-4675-4","volume":"169","author":"F Valdora","year":"2018","unstructured":"Valdora, F. et al. Rapid review: radiomics and breast cancer. Breast Cancer Res. Treat. 169, 217\u2013229. https:\/\/doi.org\/10.1007\/s10549-018-4675-4 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"35774_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11547-021-01423-y","volume":"127","author":"H Satake","year":"2022","unstructured":"Satake, H. et al. Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence. Radiol. Med. 127, 141\u2013150. https:\/\/doi.org\/10.1007\/s11547-021-01423-y (2022).","journal-title":"Radiol. Med."},{"issue":"8","key":"35774_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jacr.2015.04.019","volume":"12","author":"MA Mazurowski","year":"2015","unstructured":"Mazurowski, M. A. Radiogenomics: what it is and why it is important. J. Am. Coll. Radiol. 12(8), 862\u2013866. https:\/\/doi.org\/10.1016\/j.jacr.2015.04.019 (2015).","journal-title":"J. Am. Coll. Radiol."},{"key":"35774_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2021.106510","volume":"212","author":"XX Yin","year":"2022","unstructured":"Yin, X. X. et al. MRI radiogenomics for intelligent diagnosis of breast tumors and accurate prediction of neoadjuvant chemotherapy response \u2014 a review. Comput. Methods Programs Biomed. 212, 106510. https:\/\/doi.org\/10.1016\/j.cmpb.2021.106510 (2022).","journal-title":"Comput. Methods Programs Biomed."},{"issue":"3","key":"35774_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/jcm11030616","volume":"11","author":"CC Miretean","year":"2022","unstructured":"Miretean, C. C. et al. Radiomics in triple-negative breast cancer: new horizons in an aggressive subtype of the disease. J. Clin. Med. 11(3), 616. https:\/\/doi.org\/10.3390\/jcm11030616 (2022).","journal-title":"J. Clin. Med."},{"key":"35774_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101719","volume":"5","author":"YJ Qi","year":"2024","unstructured":"Qi, Y. J. et al. Radiomics in breast cancer: current advances and future directions. Cell Rep. Med. 5, 101719. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101719 (2024).","journal-title":"Cell Rep. Med."},{"key":"35774_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13244-023-01415-8","volume":"14","author":"B Kocak","year":"2023","unstructured":"Kocak, B. et al. CLEAR checklist for evaluation of radiomics research. Insights Imaging 14, 215. https:\/\/doi.org\/10.1186\/s13244-023-01415-8 (2023).","journal-title":"Insights Imaging"},{"issue":"2","key":"35774_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejrad.2006.08.033","volume":"61","author":"C Balleyguier","year":"2007","unstructured":"Balleyguier, C. et al. BI-RADS classification in mammography. Eur. J. Radiol. 61(2), 192\u2013194. https:\/\/doi.org\/10.1016\/j.ejrad.2006.08.033 (2007).","journal-title":"Eur. J. Radiol."},{"issue":"11","key":"35774_CR25","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.21037\/qims-22-112","volume":"12","author":"Y Deng","year":"2022","unstructured":"Deng, Y. et al. Radiomics models based on multi-sequence MRI for preoperative evaluation of MUC4 status in pancreatic ductal adenocarcinoma: a preliminary study. Quant. Imaging Med. Surg. 12(11), 5129\u20135139. https:\/\/doi.org\/10.21037\/qims-22-112 (2022).","journal-title":"Quant. Imaging Med. Surg."},{"issue":"6","key":"35774_CR26","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.220299","volume":"5","author":"OJ Omoleye","year":"2023","unstructured":"Omoleye, O. J. et al. External evaluation of a mammography-based deep learning model for predicting breast cancer in an ethnically diverse population. Radiol. Artif. Intell. 5(6), e220299. https:\/\/doi.org\/10.1148\/ryai.220299 (2023).","journal-title":"Radiol. Artif. Intell."},{"issue":"2","key":"35774_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.artmed.2006.03.002","volume":"37","author":"ME Mavroforakis","year":"2006","unstructured":"Mavroforakis, M. E. et al. Mammographic masses characterization based on localized texture and dataset fractal analysis using linear, neural and support vector machine classifiers. Artif. Intell. Med. 37(2), 145\u2013162. https:\/\/doi.org\/10.1016\/j.artmed.2006.03.002 (2006).","journal-title":"Artif. Intell. Med."},{"issue":"3","key":"35774_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3233\/XST-230332","volume":"32","author":"K Cao","year":"2024","unstructured":"Cao, K. et al. Peri-lesion regions in differentiating suspicious breast calcification-only lesions specifically on contrast enhanced mammography. J. Xray Sci. Technol. 32(3), 583\u2013596. https:\/\/doi.org\/10.3233\/XST-230332 (2024).","journal-title":"J. Xray Sci. Technol."},{"issue":"7","key":"35774_CR29","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/jpm13071104","volume":"13","author":"AM Ponsiglione","year":"2023","unstructured":"Ponsiglione, A. M. et al. A statistical approach to assess the robustness of radiomics features in the discrimination of mammographic lesions. J. Pers. Med. 13(7), 1104. https:\/\/doi.org\/10.3390\/jpm13071104 (2023).","journal-title":"J. Pers. Med."},{"key":"35774_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmpb.2018.05.017","volume":"163","author":"SG Sapate","year":"2018","unstructured":"Sapate, S. G. et al. Radiomics-based detection and characterization of suspicious lesions on full-field digital mammograms. Comput. Methods Programs Biomed. 163, 1\u201320. https:\/\/doi.org\/10.1016\/j.cmpb.2018.05.017 (2018).","journal-title":"Comput. Methods Programs Biomed."},{"issue":"2","key":"35774_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1148\/radiol.2252010845","volume":"225","author":"Z Huo","year":"2002","unstructured":"Huo, Z. et al. Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology 225(2), 519\u2013526. https:\/\/doi.org\/10.1148\/radiol.2252010845 (2002).","journal-title":"Radiology"},{"issue":"3","key":"35774_CR32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1118\/1.1644514","volume":"31","author":"H Li","year":"2004","unstructured":"Li, H. et al. Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and location. Med. Phys. 31(3), 549\u2013555. https:\/\/doi.org\/10.1118\/1.1644514 (2004).","journal-title":"Med. Phys."},{"issue":"4","key":"35774_CR33","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s13058-014-0424-8","volume":"16","author":"GL Gierach","year":"2014","unstructured":"Gierach, G. L. et al. Relationships between computer-extracted mammographic texture pattern features and BRCA1\/2 mutation status: a cross-sectional study. Breast Cancer Res. 16(4), 424. https:\/\/doi.org\/10.1186\/s13058-014-0424-8 (2014).","journal-title":"Breast Cancer Res."},{"issue":"1","key":"35774_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23383","volume":"10","author":"R Guo","year":"2024","unstructured":"Guo, R. et al. A nomogram model combining ultrasound-based radiomics features and clinicopathological factors to identify germline BRCA1\/2 mutation in invasive breast cancer patients. Heliyon 10(1), e23383. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23383 (2024).","journal-title":"Heliyon"},{"key":"35774_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40644-024-00676-w","volume":"24","author":"T Deng","year":"2024","unstructured":"Deng, T. et al. Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer. Cancer Imaging 24, 76. https:\/\/doi.org\/10.1186\/s40644-024-00676-w (2024).","journal-title":"Cancer Imaging"},{"key":"35774_CR36","unstructured":"Roy, R., Chun, J. & Powell, S. N. BRCA1 and BRCA2:"},{"key":"35774_CR37","doi-asserted-by":"publisher","unstructured":"different roles in a common pathway of genome protection. Nat. Rev. Cancer 12(1), 68\u201378. https:\/\/doi.org\/10.1038\/nrc3181 (2012)","DOI":"10.1038\/nrc3181"},{"issue":"1","key":"35774_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4048\/jbc.2019.22.e6","volume":"22","author":"L Semmler","year":"2019","unstructured":"Semmler, L., Reiter-Brennan, C. & Klein, A. BRCA1 and breast cancer: underlying mechanisms of tissue-specific tumorigenesis in mutation carriers. J. Breast Cancer 22(1), 1\u201314. https:\/\/doi.org\/10.4048\/jbc.2019.22.e6 (2019).","journal-title":"J. Breast Cancer"},{"issue":"1","key":"35774_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MNM.0000000000001310","volume":"42","author":"Y Ishiwata","year":"2021","unstructured":"Ishiwata, Y. et al. Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 18F-FDG PET\/CT images of largest metastatic lymph node. Nucl. Med. Commun. 42(1), 86\u201392. https:\/\/doi.org\/10.1097\/MNM.0000000000001310 (2021).","journal-title":"Nucl. Med. Commun."},{"key":"35774_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.595430","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Additional value of PET\/CT-based radiomics to metabolic parameters in diagnosing Lynch syndrome and predicting PD-1 expression in endometrial carcinoma. Front. Oncol. 11, 595430. https:\/\/doi.org\/10.3389\/fonc.2021.595430 (2021).","journal-title":"Front. Oncol."},{"key":"35774_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12880-023-01022-5","volume":"23","author":"WJ Xu","year":"2023","unstructured":"Xu, W. J. et al. Identification of triple-negative breast cancer and androgen receptor expression based on histogram and texture analysis of dynamic contrast-enhanced MRI. BMC Med. Imaging 23, 102. https:\/\/doi.org\/10.1186\/s12880-023-01022-5 (2023).","journal-title":"BMC Med. Imaging"},{"key":"35774_CR42","doi-asserted-by":"publisher","first-page":"107327482210894","DOI":"10.1177\/10732748221089408","volume":"29","author":"T Zhang","year":"2022","unstructured":"Zhang, T., Li, X. & Liu, J. Prediction of the invasiveness of ground-glass nodules in lung adenocarcinoma by radiomics analysis using high-resolution computed tomography imaging. Cancer Control 29, 10732748221089408. https:\/\/doi.org\/10.1177\/10732748221089408 (2022).","journal-title":"Cancer Control"},{"issue":"2","key":"35774_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1148\/radiol.2015142304","volume":"276","author":"BN Dontchos","year":"2015","unstructured":"Dontchos, B. N. et al. Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk?. Radiology 276(2), 371\u2013380. https:\/\/doi.org\/10.1148\/radiol.2015142304 (2015).","journal-title":"Radiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35774-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35774-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35774-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:27:17Z","timestamp":1773307637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35774-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35774"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35774-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study has been approved by the local ethical committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"8765"}}